Please wait



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)


X0202 SCHEDULE 13D/A 0001493152-25-017501 0001568078 XXXXXXXX LIVE 1 Common Stock, par value $0.0001 per share 07/31/2026 false 0001938569 909233108 Palomino Laboratories Inc. 130 Castilian Drive, Suite 102 Goleta CA 93117 Richard Ogawa 704-756-2981 C/O 130 Castilian Drive, Suite 102 Goleta CA 93117 0001568078 N Richard Ogawa b OO N X1 1882500.00 0.00 1882500.00 0.00 1882500.00 N 6.9 IN Common Stock, par value $0.0001 per share Palomino Laboratories Inc. 130 Castilian Drive, Suite 102 Goleta CA 93117 The business address of the Reporting Person is 130 Castilian Drive, Suite 102, Goleta, CA 93117 Item 3 is being amended and supplemented by adding the following: On July 31, 2026, pursuant to the terms of a Share Exchange Agreement and Plan of Reorganization (the "Share Exchange Agreement") by and among the Issuer, Vega Links, Inc. ("VLI"), and VLI's stockholders (the "Stockholders"), the Stockholders who directly owned all of the issued and outstanding equity interests of VLI amounting to 11,180,000 shares of common stock (the "Shares"), exchanged all the Shares for 4,472,000 shares of the Palomino Common Stock. As part of this transaction, the Reporting Person, a VLI shareholder, received 120,000 shares of the Issuer (the "Consideration Shares") in exchange for his 300,000 shares of VLI. The Reporting Person acquired the Consideration Shares pursuant to the Share Exchange Agreement. The information contained in Item 3 of this Schedule 13D is incorporated herein by reference. The Reporting Person serves as the Secretary and a director of the Issuer. Accordingly, the Reporting Person may have influence over the corporate activities of the Issuer, including activities that may relate to items described in clauses (a) through (j) of Item 4 of this Schedule 13D. Except as described in this Schedule 13D, the Reporting Person does not have any present plans or proposals that relate to or would result in any of the actions described in clauses (a) through (j) of Item 4 of this Schedule 13D. The Reporting Person reserves the right to formulate plans and/or proposals and to take such actions with respect to their investment in the Issuer, including any or all of the actions set forth in clauses (a) through (j) of Item 4 of this Schedule 13D. Item 5 is being amended and replaced by the following: As of the date of this Amendment No. 1, the Reporting Person beneficially owns 1,882,500.00 shares of Palomino Common Stock, of which 125,000 shares of Palomino Common Stock are issuable upon exercise of a warrant held by the Reporting Person. 6.9% 1,882,500.00 There have been no other transactions in the shares of Palomino Common Stock effected by the Reporting Person during the past 60 days. No person other than the Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares reported as being beneficially owned by the Reporting Person. N/A The information set forth in Item 3 is incorporated herein by reference. Vesting Schedule: The Consideration Shares held by the Reporting Person are subject to vesting in accordance with the Reporting Person's existing stock purchase agreement executed with VLI. 99.1 Share Exchange Agreement and Plan of Reorganization, dated July 31, 2026, by and among the Issuer, VLI and the Stockholders (incorporated by reference to Exhibit 2.1 to the Issuer's Current Report on Form 8-K as filed with the SEC on August 4, 2026). Richard Ogawa /s/ Richard Ogawa Richard Ogawa 08/21/2026